EyePoint Pharmaceuticals, Inc. 30233G209 06/20/2024 To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the published proxy statement. SECTION 14A SAY-ON-PAY VOTES 13498233 0 FOR 13498233 FOR MiMedx Group, Inc. 602496101 06/05/2024 To approve, on an advisory basis, the Company's executive compensation. SECTION 14A SAY-ON-PAY VOTES 28195249 0 FOR 28195249 FOR